Therefore, while the atrogin-1–mediated BiP may not be involved in the loss in fiber integrity seen in DMD, it does contribute to the reduction in muscle function, making this disease axis therapeutically relevant for potentially improving muscle performance in boys with DMD. This evidence concerns the gene FBXO32 and Duchenne muscular dystrophy.